About this trial
This study aims to describe conservative and invasive treatments for patients with chronic venous disease (CVD) in Belgium, and their association with clinical and patient-reported outcomes during a follow-up of 24 months.
Eligibility criteria
Qualifiers
Patient receiving the diagnosis of CVD from the GP during the V0, according to international guidelines and made on a clinical basis,
Patient requiring and agreeing to receive conservative or invasive treatment,
French or Dutch speaking patient,
Patient signed informed consent and agrees to take part in the study and follow-up.
Disqualifiers
Patient with coagulation disorders such as thrombophilia and/or taking anticoagulation drugs,
Pregnant or breastfeeding patient,
Patient with severe Peripheral Arterial Occlusive Disease (POAD), with Ankle Brachial Index (ABI) < 0.8,
Patient with malignancy,
Trial design
Treatments tested in this trial
- Radiofrequency ablation using Closure fast
- Aethoxysclerol
- Daflon
- Compression stocking